Tg(Myh6-GCaMP8)B4-10Mik
Transgene Detail
|
Symbol: |
Tg(Myh6-GCaMP8)B4-10Mik |
Name: |
transgene insertion B4-10, Michael I Kotlikoff |
MGI ID: |
MGI:6294066 |
Synonyms: |
aMHC-GCaMP8, B4-Myh6-GCaMP8 |
Transgene: |
Tg(Myh6-GCaMP8)B4-10Mik Location: unknown
|
Alliance: |
Tg(Myh6-GCaMP8)B4-10Mik page
|
|
Strain of Origin: |
FVB/N X B6(Cg)-Tyrc-2J/J
|
|
Transgene Type: |
|
Transgenic (Reporter) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The transgene was designed with (from 5' to 3') a ~5.5 kbp mouse Myh6 minimal promoter sequence (including the 3' most exon of betaMHC, the first three exons of alphaMHC [up to the start codon] as well as intervening sequences) and a ~1950 bp GCaMP8-hGHpA construct. GCaMP8 is composed of (from N-term to C-term) a polyHis plasmid leader sequence essential for thermal stability (RSET with the ΔH and ΔR2 mutations), a 20 residue peptide of chicken smooth muscle myosin light chain kinase (M13; target peptide for a Ca2+-bound CaM), a circularly permutated EGFP (cpEGFP; aa 149-238 followed by aa 1-144 [with mutations listed below]), a rat calmodulin DNA fragment (CaM; aa 2-148). Founder line B4-10 was identified with high sensor expression in cardiomyocytes.
(J:314125)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:314125 Lee FK, et al., Genetically engineered mice for combinatorial cardiovascular optobiology. Elife. 2021 Oct 29;10:e67858 |
All: |
2 reference(s) |
|